Seres Therapeutics (MCRB) Other Non-Current Assets (2014 - 2026)
Seres Therapeutics' Other Non-Current Assets was $2.24 million in Q2 2026, down 74.1% from $8.67 million a year earlier and down 74.1% from the prior quarter.
Seres Therapeutics (MCRB) Other Non-Current Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, Other Non-Current Assets at Seres Therapeutics came in at $8.67 million, unchanged from FY2024.
- Other Non-Current Assets shows a four-year compound annual growth rate of 2.0% (FY2021 to FY2025).
- In earlier years, Other Non-Current Assets was $8.67 million in FY2024 (-86.3%), $63.39 million in FY2023 (+505.7%), $10.47 million in FY2022 (+30.8%) and $8 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly Other Non-Current Assets since Q3 2021.
- The best year-over-year quarter for Other Non-Current Assets over five years was Q4 2023 (growth of 505.7%); the worst was Q4 2024 (a decline of 86.3%).
- Per Business Quant data, MCRB's Other Non-Current Assets in the three quarters before Q2 2026 was $8.67 million (Q1 2026), $8.67 million (Q4 2025) and $8.67 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 7.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 14.27 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 10.73 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 19.60 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 12.98 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 4.75 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 9.94 Bn |
| 10 | Seres Therapeutics | 22.42 Mn | -116.41 Mn | - | 2.27 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.27 Mn |
| Mar 31, 2026 | 8.70 Mn |
| Dec 31, 2025 | 8.70 Mn |
| Sep 30, 2025 | 8.70 Mn |
| Jun 30, 2025 | 8.70 Mn |
| Mar 31, 2025 | 8.70 Mn |
| Dec 31, 2024 | 8.70 Mn |
| Sep 30, 2024 | 10.34 Mn |
| Jun 30, 2024 | 51.39 Mn |
| Mar 31, 2024 | 49.90 Mn |
| Dec 31, 2023 | 73.76 Mn |
| Sep 30, 2023 | 20.23 Mn |
| Jun 30, 2023 | 19.44 Mn |
| Mar 31, 2023 | 19.49 Mn |
| Dec 31, 2022 | 18.65 Mn |
| Sep 30, 2022 | 19.72 Mn |
| Jun 30, 2022 | 17.69 Mn |
| Mar 31, 2022 | 9.93 Mn |
| Dec 31, 2021 | 13.19 Mn |
| Sep 30, 2021 | 601,000.00 |
Seres Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=MCRB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "MCRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=MCRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();